Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more
Cowealth Medical Holding Co Ltd (4745) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.018x
Based on the latest financial reports, Cowealth Medical Holding Co Ltd (4745) has a cash flow conversion efficiency ratio of -0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-85.86 Million) by net assets (NT$4.71 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cowealth Medical Holding Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Cowealth Medical Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cowealth Medical Holding Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cowealth Medical Holding Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Provectus Biopharmaceuticals Inc
OTCQB:PVCT
|
0.136x |
|
Robo.ai Inc.
NASDAQ:AIIO
|
0.060x |
|
Alkindo Naratama Tbk
JK:ALDO
|
-0.038x |
|
King Stone Energy Group Limited
PINK:YNSKF
|
0.004x |
|
Vivid Seats Inc
NASDAQ:SEAT
|
0.002x |
|
Mercor S.A.
WAR:MCR
|
-0.262x |
|
Shengli Oil & Gas Pipe Holdings Limited
F:GSG
|
-0.162x |
|
PEBBLE BEACH SYS. LS-025
F:VSF
|
N/A |
Annual Cash Flow Conversion Efficiency for Cowealth Medical Holding Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Cowealth Medical Holding Co Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$5.19 Billion | NT$373.97 Million | 0.072x | +704.12% |
| 2023-12-31 | NT$5.03 Billion | NT$45.02 Million | 0.009x | +117.41% |
| 2022-12-31 | NT$5.20 Billion | NT$-267.59 Million | -0.051x | -53.18% |
| 2021-12-31 | NT$3.53 Billion | NT$-118.38 Million | -0.034x | -114.32% |
| 2020-12-31 | NT$3.43 Billion | NT$804.75 Million | 0.235x | +673.55% |
| 2019-12-31 | NT$3.34 Billion | NT$-136.78 Million | -0.041x | -157.89% |
| 2018-12-31 | NT$1.89 Billion | NT$133.64 Million | 0.071x | -13.07% |
| 2017-12-31 | NT$1.66 Billion | NT$135.26 Million | 0.081x | -- |